Search

This section offers news briefs on the pharmaceutical industry. It presents highlights from the September 2011 issue of Medsafe New Zealand's "Presciber Update." Batches of busulfan and bortezomib will be recalled in Great Britain due to a theoretical risk of contamination, according to an alert from the Medicines and Healthcare products Regulatory Agency (MHRA). The Australian Therapeutic Goods Administration (TGA) will develop a consultation paper on the labelling and packaging of medicines.

The article reports on the decision of periodical "PharmacoEconomics" to dedicate its September 2008 issue to the fourth hurdle set by the British National Institute for Clinical Excellence (NICE) requiring pharmaceutical companies to demonstrate the cost effectiveness of their products. The issue addressed the health technology assessment and the cost-effectiveness rating and attaining National Health Service (NHS) reimbursement. It also includes the original briefing papers commissioned by NICE to inform companies of the requirements.